George Peter Lomonossoff

USPTO Granted Patents = 11 (Patent Applications = 6)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 85(Granted Patents)

Location History:

Norfolk, GB (2005 - 2020)
Norwich, GB (1997 - 2021)

Company Filing History:

4 out of 79

Plant Bioscience Limited

Purdue Research Foundation

patents

4. 2 out of 1,521

Cornell Research Foundation Inc.

patents

5. 2 out of 7,680

The Dow Chemical Company

patents

where one patent can have more than one assignee

Years Active: 1997-2021

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10947549 - Protein expression systems (2021-03-16),

2. 10822613 - Protein expression systems (2020-11-03),

3. 8674084 - Protein expression system (2014-03-18),

4. 8519113 - Bipartite system, method and composition for the constitutive and inducible expression of high levels of foreign proteins in plants (2013-08-27),

5. 7208655 - Modified plant viruses as vectors (2007-04-24),

6. 6884623 - Modified plant viruses as vectors of heterologous peptides (2005-04-26),

7. 6649813 - Induction of resistance to virus diseases by transformation of plants with a plant virus replicase gene (2003-11-18),

8. 6110466 - Modified plant viruses as vectors (2000-08-29),

9. 5958422 - Modified plant viruses as vectors of heterologous peptides (1999-09-28),

10. 5874087 - Modified plant viruses as vectors (1999-02-23),

11. 5596132 - Induction of resistance to virus diseases by transformation of plants (1997-01-21),

Title: The Innovations of George Peter Lomonossoff

Introduction

George Peter Lomonossoff is a prominent inventor based in Norwich, GB. He has made significant contributions to the field of protein expression systems, holding a total of 11 patents. His work has advanced the understanding and application of viral RNA in biotechnology.

Latest Patents

Lomonossoff's latest patents focus on innovative protein expression systems. These inventions are based on an expression enhancer sequence derived from the RNA-2 genome segment of a bipartite RNA virus. By mutating a target initiation site in the RNA-2 genome segment, he has demonstrated that the deletion of appropriate start codons upstream of the main RNA2 translation initiation can greatly increase foreign protein accumulation without the need for viral replication. Additionally, he has provided methods, vectors, and systems, including the 'hyper-translatable' Cowpea Mosaic Virus ('CPMV-HT') based protein expression system.

Career Highlights

Throughout his career, Lomonossoff has worked with notable companies such as Plant Bioscience Limited and Axis Genetics Plc. His expertise in the field has led to numerous advancements in protein expression technologies.

Collaborations

Lomonossoff has collaborated with several professionals in his field, including John Emil Johnson and Frank Sainsbury. These partnerships have contributed to the success of his innovative projects.

Conclusion

George Peter Lomonossoff's contributions to protein expression systems have had a lasting impact on biotechnology. His innovative patents and collaborations continue to influence the field, showcasing the importance of his work.

This text is generated by artificial intelligence and may not be accurate.